openPR Logo
Press release

Emerging Growth Patterns Driving Expansion in the Contraceptives Market

12-17-2025 09:30 AM CET | Health & Medicine

Press release from: The Business Research Company

Contraceptives Market

Contraceptives Market

The contraceptives market is positioned for significant expansion in the coming years, driven by several evolving factors and innovations. As awareness and accessibility grow worldwide, the sector is adapting to meet diverse needs through advanced technologies and broader availability. Below is a detailed exploration of the market size, key players, trends, and segment dynamics shaping the contraceptives industry.

Projected Growth and Market Size of the Contraceptives Industry
The contraceptives market is expected to experience robust growth, reaching $40 billion by 2029 with a compound annual growth rate (CAGR) of 7.7%. This upward trajectory is fueled by increasing attention on male contraceptive options, improved access to contraception in developing regions, and the incorporation of digital health technologies into contraceptive care. Rising demand for long-acting reversible contraceptives (LARCs) and the greater availability of over-the-counter options through online platforms also contribute to this growth. Key trends influencing the market include advancements in contraceptive technology, a shift toward non-hormonal and natural methods, expanded over-the-counter availability, focus on discreet and user-friendly products, and the growing role of telemedicine in counseling and prescription services.

Download a free sample of the contraceptives market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Important Drivers Behind the Contraceptives Market Expansion
A growing focus on male contraception is one of the critical factors propelling the market forward. This expanding interest helps diversify contraceptive options beyond traditional female-centric methods, encouraging wider acceptance and use among men.
Additionally, increasing access to contraceptive products in developing countries plays a vital role. Enhanced healthcare infrastructure and awareness campaigns are enabling more individuals to obtain contraceptives, particularly in regions where usage had previously been limited.

Leading Companies Dominating the Contraceptives Market
The contraceptives market includes several prominent players such as Merck & Co. Inc., Bayer AG, Church & Dwight* Co. Inc., Cipla Inc., and Reckitt Benckiser Group plc. Others active in the space are Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., and Glenmark Pharmaceuticals Limited. Additional key names include HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., and Chongqing Pharmaceutical Group Co. Ltd.

View the full contraceptives market report:
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Recent Market Moves Highlighted by Insud Pharma's Acquisition
In March 2024, Spain-based Insud Pharma, a pharmaceutical manufacturer, acquired the oral and injectable contraceptives portfolio from Viatris, a US pharmaceutical company, for an undisclosed sum. This purchase allows Insud Pharma to broaden its women's health product offerings, strengthening its position in reproductive healthcare. By integrating Viatris' contraceptive products, Insud Pharma aims to meet increasing demand with a wider range of contraceptive solutions.

Emerging Innovations and Opportunities in the Contraceptives Sector
Industry leaders are focusing on developing new contraceptive technologies such as Single Rod Subdermal Implants and Subcutaneous Injectable Contraceptives. These novel methods emphasize convenience, improved efficacy, and long-term birth control, reducing the need for frequent dosing.
For example, in October 2023, India's Health and Family Welfare Ministry introduced these two new contraceptive options under the National Family Planning Programme to enhance family planning services. The initiative supports improved maternal and infant health by offering safer and more effective contraceptive choices. This reflects a broader effort to upgrade reproductive health services, particularly in Karnataka, ensuring women have access to advanced and reliable contraceptive methods.

Market Segmentation and the Largest Contraceptive Product Share
The contraceptives market is segmented across several categories:
1) Product Types: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, and Intra-Uterine Devices (IUDs)
2) Age Groups: 15-24 Years, 25-34 Years, 35-44 Years, and 44 Years and above
3) Distribution Channels: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, and Other Channels

Further subcategories include:
- Oral Contraceptive Pills divided into Combination Pills and Progestin-Only Pills
- Topical Contraceptives including Transdermal Patches and Gel Applications
- Injectables split into Hormonal and Non-Hormonal Injectables
- Diaphragms consisting of Silicone and Latex variants
- Vaginal Rings divided into Hormonal and Non-Hormonal types
- Condoms categorized as Male and Female Condoms
- Contraceptive Sponges split into Non-Hormonal and Hormonal options
- Subdermal Implants including Hormonal and Non-Hormonal forms
- IUDs divided into Hormonal and Copper types

This detailed segmentation highlights the diverse range of contraceptive products designed to meet the varied needs of users across different demographics and preferences.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerging Growth Patterns Driving Expansion in the Contraceptives Market here

News-ID: 4318619 • Views:

More Releases from The Business Research Company

Smart Pill Dispenser Market Analysis Highlights Growth To $5.54 Billion By 2030 At 11.9% CAGR
Smart Pill Dispenser Market Analysis Highlights Growth To $5.54 Billion By 2030 …
The smart pill dispenser market is gaining significant momentum with promising growth prospects expected over the coming years. This expanding sector is being shaped by technological advancements and increasing demand for efficient medication management solutions, particularly as healthcare delivery continues to evolve toward remote and connected care models. Let's explore the market's projected growth, key players, emerging trends, and detailed segmentation. Forecasted Growth and Market Value of the Smart Pill Dispenser
Smart Orthopedic Implants Market Report 2026 Market Outlook Supported By A Forecast 5.1% CAGR
Smart Orthopedic Implants Market Report 2026 Market Outlook Supported By A Forec …
The smart orthopedic implants market is set to experience substantial growth as technological advancements and demographic shifts drive demand. Innovations in sensor technology and artificial intelligence are transforming orthopedic care, offering more personalized and effective treatment options. This evolving sector is attracting significant attention from both established players and new entrants aiming to capitalize on emerging opportunities. Projected Growth Trajectory for the Smart Orthopedic Implants Market Through 2030 The smart
Smart Mattress Overlay (Hospital) Market Outlook Highlights Strategic Opportunities Across The Industry
Smart Mattress Overlay (Hospital) Market Outlook Highlights Strategic Opportunit …
The smart mattress overlay (hospital) market is set to undergo significant expansion in the coming years, driven by advancements in healthcare technology and increasing demand for improved patient care solutions. This market is poised to transform hospital infrastructure and patient management by integrating intelligent systems designed for enhanced monitoring and comfort. Let's explore the market's size, key players, trends, and segmentation to understand its future trajectory. Market Size Outlook and Growth
Smart Infusion Pumps Market Research Reveals Strong 9.2% CAGR Outlook Through 2030
Smart Infusion Pumps Market Research Reveals Strong 9.2% CAGR Outlook Through 20 …
The smart infusion pumps market is on the brink of significant expansion driven by ongoing technological advancements and growing healthcare demands. As healthcare providers seek safer and more efficient drug delivery solutions, smart infusion pumps are becoming increasingly vital. Let's explore the market size, key players, emerging trends, and major segments shaping this industry's future. Projected Growth and Market Size of the Smart Infusion Pumps Market The smart infusion pumps

All 5 Releases


More Releases for Pharma

Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring